- Pharmaceutical companies
- Europe
- Italy
- Jazz Pharmaceuticals
Jazz Pharmaceuticals in Italy
Web: https://www.jazzpharma.com/
Address:
-
Gentium S.P.A. Piazza XX Settembre, 2 22079 Villa Guardia CO Italy
Phone: +39 031 537 3200
Other Jazz Pharmaceuticals's locations around the world
Clinical Trials sponsored by Jazz Pharmaceuticals
-
Jazz PharmaceuticalsRekrutierungTuberöse Sklerose-Komplex-assoziierte neuropsychiatrische ErkrankungVereinigte Staaten, Vereinigtes Königreich, Polen
-
Jazz PharmaceuticalsRekrutierungParkinson Krankheit | TremorVereinigte Staaten, Spanien, Deutschland, Polen
-
Jazz PharmaceuticalsRekrutierungSolider Krebs | Metastasierender Krebs | Fortgeschrittener KrebsVereinigte Staaten
-
Jazz PharmaceuticalsRekrutierungTuberöse Sklerose-Komplex | Dravet-Syndrom | Lennox-Gastaut-SyndromVereinigte Staaten
-
Jazz PharmaceuticalsRekrutierung
-
Jazz PharmaceuticalsAktiv, nicht rekrutierendHER2-exprimierende Magen-Darm-Krebsarten, einschließlich gastroösophagealem Adenokarzinom, Gallengangskrebs und DarmkrebsVereinigte Staaten, Korea, Republik von, Chile, Kanada
-
Jazz PharmaceuticalsAktiv, nicht rekrutierendHER2-exprimierende KrebsartenVereinigte Staaten, Kanada, Korea, Republik von
-
Jazz PharmaceuticalsAbgeschlossenFortgeschrittener solider Tumor | Metastasierter solider Tumor | Urothelkrebs | Schlecht differenzierte neuroendokrine Karzinome | Homologe Rekombination defizient-positive Malignome AgnostischVereinigte Staaten
-
Jazz PharmaceuticalsBeendetSpastik bei Multipler SkleroseSpanien, Vereinigte Staaten, Vereinigtes Königreich, Tschechien, Polen
-
Jazz PharmaceuticalsAktiv, nicht rekrutierendGesunde TeilnehmerVereinigte Staaten
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients. We are focused on developing life-changing medicines for people with serious diseases — often with limited or no options — so they can live their lives more fully. By transforming biopharmaceutical discoveries into novel medicines, we are working to give people around the world the opportunity to redefine what’s possible – to make the “small wins” big again. Through continued investment in an evolving and growing research and development focus, we seek solutions for rare or complex diseases, and ensure those solutions are available for the often-overlooked patients who need them. Our approach has allowed us to shepherd new medicines to market – from late-stage discovery through clinical development and regulatory approval. All of these advancements are a reflection of our continued investment in an evolving and growing research and development focus.